Health
FDA found no violations at trial sites regarding Pfizer’s Lyme disease vaccine
A U.S. health regulator found no violations at clinical centres run by Care Access for Pfizer and French partner Valneva in a trial of a
More than 7 million Americans have received updated COVID vaccines
According to the US Department of Health and Human Services, more than 7 million Americans have received the updated COVID-19 vaccines, despite reports that some
India clears cough syrup firm linked to Uzbek deaths
The northern Indian state of Uttar Pradesh has authorised the resumption of most of the production at a plant owned by Marion Biotech that made
Court approves Mallinckrodt restructuring and $1 billion cut in opioid reimbursement
Pharmaceutical company Mallinckrodt has received court approval for a bankruptcy plan that reduces by $1 billion the amount it owes to victims of the opioid
Drug maker GSK settles another lawsuit in California over heartburn drug Zantac
GSK on Wednesday said it would confidentially settle another lawsuit in California alleging that its discontinued heartburn drug Zantac caused cancer, as the British drugmaker
Alnylam refuses to expand the use of heart disease drugs in the U.S.
Alnylam Pharmaceuticals said it will not expand the use of its drug to treat a potentially fatal heart condition in the U.S. after the Food
The number of U.S. employers paying for weight-loss drugs could nearly double in 2024
The number of U.S. employers paying for obesity drugs, including Novo Nordisk’s Wegovy, which belongs to the GLP-1 class of drugs, could nearly double next
AnaptysBio skin disease drug reaches major late-stage study target
AnaptysBio said its experimental drug to treat one of the rare skin diseases has achieved the primary endpoint of a late-stage study. The drug helped
Gates donates $40 million to boost access to mRNA vaccines in Africa
The Bill & Melinda Gates Foundation will donate $40 million to a Belgian biotech company and two leading African vaccine manufacturers in a bid to
Bristol-Myers Squibb to acquire Mirati for $5.8 billion
Bristol-Myers Squibb announced it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can